Edition:
United States

Evotec announces strategic investment in Facio Therapies


Tuesday, 20 Jun 2017 01:30am EDT 

June 20 (Reuters) - Evotec AG :Announces strategic investment in Facio Therapies to support development of novel FSHD therapy.Says to participate in Facio Therapies' 2017 funding round alongside members of FSHD community (total volume: 4.8 mln euros).